About Helsinn group
Helsinn Group: A Pioneer in Cancer Supportive Care and Oncology Therapeutics
Helsinn Group is a Swiss biopharmaceutical company that has been at the forefront of cancer supportive care and oncology therapeutics for over 40 years. The company's innovative R&D pipeline focuses on developing small molecules in precision medicine with higher market potential, thanks to a consolidated track record, a solid revenue stream in B2B, and strong cash flow and cash position.
The Helsinn Group was founded in 1976 by Dr. Gabriele Braglia, who had a vision to create innovative therapies that would improve the quality of life for cancer patients. Today, the company has grown into an international organization with offices around the world.
One of Helsinn's key strengths is its focus on cancer supportive care. This approach recognizes that treating cancer involves more than just attacking tumors; it also requires managing symptoms such as pain, nausea, and fatigue. By developing drugs that address these issues, Helsinn helps patients feel better during their treatment and recover more quickly afterward.
In addition to its work in supportive care, Helsinn is also involved in oncology therapeutics. The company's research focuses on developing targeted therapies that attack specific types of cancer cells while leaving healthy cells unharmed. This approach can be more effective than traditional chemotherapy because it minimizes side effects.
To support its research efforts, Helsinn has invested heavily in building a fully integrated targeted therapy structure. This includes facilities for drug development and manufacturing as well as commercialization capabilities to bring new treatments to market quickly.
Despite its focus on innovation and cutting-edge research, Helsinn remains committed to maintaining high ethical standards throughout all aspects of its business operations. The company adheres strictly to all applicable laws and regulations governing pharmaceuticals while also prioritizing patient safety above all else.
Overall, the Helsinn Group is an impressive organization with a long history of success in the biopharmaceutical industry. Its commitment to improving patient outcomes through innovative therapies makes it one of the most respected companies working today – both within Switzerland and around the world.
SEO Keywords:
- Swiss Biopharmaceutical Group
- Cancer Supportive Care
- Precision Medicine
- Targeted Therapy Structure
- Innovative Therapies
- Patient Safety